BSX’s Watchman Gets Fall Panel Date: Is Third Time the Charm?

Devices & Diagnostics Letter
A A
Boston Scientific’s Watchman stroke-prevention device will get its third go before the FDA’s Circulatory Devices Panel next month.

To View This Article:

Login

Subscribe To Devices & Diagnostics Letter

Buy This Article Now

Add this article to your cart for $25.00